|
|
|
|
|
|
| Managing Supply For Complex Biotherapeutics | Article | By Iwan Bertholjotti, Lonza | Antibody-drug conjugates' manufacturing supply chain contains five different technologies with specific asset needs: monoclonal antibody, cytotoxic payload, linker, bioconjugation, and fill/finish. |
|
|
| Achieving Ophthalmic Production | Article | By John Teixeira, Jubilant HollisterStier | A partner with state-of-the-art facilities can guarantee efficient and scalable production of ophthalmic solutions, drops, and ointments, and is critical as you navigate the complexities of ophthalmic production. |
|
|
|
| Critical Supply Strategies For CROs | White Paper | Catalent | Leveraging the expertise of a chosen clinical supply partner can be a valuable resource. Examine key considerations when partnering with a CRO in order to deliver a successful clinical supply strategy. |
|
|
|
| Lyobeads Are The Hottest Thing In Freeze Drying For Pharma | Article | By Brandon Cole, ATS Life Sciences Scientific Products | If the lyophilization process is applied to a single droplet of liquid, it creates a lyo ‘bead’ rather than a lyo 'cake.' Discover the potential of lyobeads and why they are an excellent alternative. |
|
|
|
|
| Nanoforming: The Patient- And Planet-Centric Approach | Webinar | Nanoform | By reducing the size of drug particles, nanoforming can open up new opportunities — from increasing bioavailability to enabling sustained drug delivery. Discover the potential benefits supported by case studies. |
|
|
|
|
|
|
By Matthew Pillar, Editor, Bioprocess Online
| The early use cases for AI in the industry — at least, the early public use cases — have largely come from R&D, and more specifically, target identification and molecular design. Where are the use cases in biologics manufacturing, supply chain management, QMS, and operations, and what’s holding us back? |
|
|
|
|
|
|
|
|
Connect With Pharmaceutical Online: |
|
|
|